Displaying drugs 9651 - 9675 of 9795 in total
Lasalocid
Lasalocid is an agent that presents antibacterial and coccidiostat activities. It is produced by strains of Streptomyces lasaliensis.
Vet approved
Matched Categories: … Membrane Transport Modulators …
ORE-1001
ORE1001 has been used in trials studying the treatment of Mild to Moderate Ulcerative Colitis. It is an ACE2 inhibitor.
Investigational
UK-500001
UK-500,001 has been used in trials studying the treatment of Pulmonary Disease, Chronic Obstructive.
Investigational
Lorajmine
Experimental
GLPG-0259
GLPG-0259 is under investigation in clinical trial NCT01024517 (GLPG0259 Solid Formulation Bioavailability and Food Effect).
Investigational
5'-O-(L-Cysteinylsulfamoyl)adenosine
Experimental
3-(alpha-D-Galactopyranosyloxy)-5-nitrobenzamide
Experimental
Acid yellow 54 free acid
Experimental
Tmr
Experimental
PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE
Experimental
AZD-4547
AZD4547 has been used in trials studying the treatment of Cancer, LYMPHOMA, Gastric Cancer, Adenocarcinoma, and Solid Neoplasm, among others.
Investigational
Pyridoxyl-Glutamic Acid-5'-Monophosphate
Experimental
5'-O-(L-Threonylsulfamoyl)adenosine
Experimental
N-(5'-phosphopyridoxyl)-L-alanine
Experimental
N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE
Experimental
Cimicoxib
Cimicoxib is a selective COX-2 inhibitor being developed by Affectis as a treatment for depression and schizophrenia. If approved, Cimicoxib would be the first drug in decades to treat depression by a new mechanism of action.
Investigational
Displaying drugs 9651 - 9675 of 9795 in total